Le Lézard
Classified in: Health
Subject: ACC

Aker ASA - Buyback of bonds


OSLO, Norway, Jan. 10, 2024 /PRNewswire/ -- Reference is made to the stock exchange notice on 9 January 2024 regarding the successful placement of new senior unsecured bonds issued by Aker ASA. In conjunction with the bond issuance Aker ASA has bought back a nominal amount of NOK 503.5 million of bonds maturing 22 November 2024 (with ticker AKER15 and ISIN NO0010868979).

For further information, please contact:

Fredrik Berge,
Head of Investor Relations Aker ASA
Tel: +47 45 03 20 90
E-mail: [email protected] 

This information is subject to the disclosure requirements pursuant to section 5 -12 the Norwegian Securities Trading Act.

 

 

 


These press releases may also interest you

at 09:05
Masimo to Present in BofA Securities Health Care Conference
Masimo today announced that its management will participate in the BofA Securities Health Care Conference on Wednesday, May 15, 2024 at 4:20 p.m. Pacific Time. A live webcast of the presentation will be available on the Masimo website at...

at 09:05
100th Patient Milestone with Epione® Achieved at US Hospital
This week, Epione will celebrate another milestone at a leading cancer institute where the 100th patient will be treated using the technology. Epione, a robotic- assisted platform used in interventional oncology, is designed to support physicians...

at 09:05
CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer
CEL-SCI Corporation today announced a significantly positive outcome from its recent meeting with the U.S. Food and Drug Administration (FDA) regarding the path to approval for its first-line investigational cancer immunotherapy Multikine*...

at 09:05
Dr. Vince Clinical Research Appoints World-Renowned Drug Developer, Clinical Pharmacologist and Neuroscientist Dr. Sheldon Preskorn as Senior VP of Neuroscience
Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO), today announced the appointment of Sheldon Preskorn, M.D., as its Senior Vice President of Neuroscience. Dr. Preskorn is a world-renowned researcher, academic...

at 09:05
Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced that Joshua Cohen and Justin Klee, Co-CEOs of Amylyx, and Camille L. Bedrosian, MD, Chief Medical Officer of Amylyx, will participate in the 2024 Bank of America Health Care...

at 09:00
A 40-Bed Physical Rehab Hospital in N.E. San Antonio, Texas is Announced Under Construction by Everest Rehabilitation Hospitals (their 17th location and 3rd in the city)
Today, Everest Rehabilitation Hospitals announced plans to construct a 40-bed inpatient physical rehabilitation hospital in N.E. San Antonio, specifically in Live Oak, Texas will be Everest's third location in the San Antonio Metroplex. We believe...

More news about Health...


News published on and distributed by: